Revised Azilect Labeling Allows Use With OTC Cough, Cold Drugs

摘要

The FDA has approved revised labeling for Teva Pharmaceutical Industries' Parkinson's disease drug Azilect, cutting back on warnings against simultaneous use of certain medications and foods.rnThis decision removes contraindications on the drug's labeling so additional patients can take it, Teva says in a statement last week.